Home > Press > QuantumSphere Unveils Word’s First Pure Magnetic Nanopowder
Abstract:
Magnetic Nanopowders Significantly Advance Medical Diagnostic Results Previously Undetectable Using Conventional Technology
QuantumSphere today announced that
it has unveiled the first pure magnetic nanopowder for biomedical
applications. QuantumSphere produces, manufactures and sells magnetic
nanopowder based on a material that is not harmful to the body.
QuantumSphere’s magnetic nanopowder will be used to dramatically enhance
Magnetic Resonance Imaging (MRI) applications. MRI technology can be
leveraged in conjunction with QuantumSphere’s magnetic nanoparticles to
focus electromagnetic energy waves into the body to view internal organs
better, such as the liver, to see damage, or investigate the functions of
internal organs. QuantumSphere’s magnetic nanopowders offer
orders-of-magnitude performance improvements when compared to existing
imaging materials, such as gadolinium dies, and other standard materials
used today. Entities such as General Electric, Walter Reed Army Medical
Center, and leading academic institutions such as the Mayo Clinic can
significantly benefit from this advance.
“QuantumSphere’s introduction of magnetic nanopowders, backed by our
mass-scale manufacturing and production capability, marks a milestone in the
evolution of science, research and patient treatment. By leveraging our
magnetic nanopowders, research institutions and companies alike will enjoy
orders-of-magnitude performance improvements in MRI resolution and imaging,
better diagnoses and patient treatment,” said Dr. Douglas Carpenter, Chief
Scientific Officer and Director of Research and Development, QuantumSphere,
Inc. “QuantumSphere’s metallic nanopowders enable users to leverage
cutting-edge technology that vastly improves the understanding of disease
and organ function. The use of our product will ignite awareness and
advances in the MRI field as our nanopowders offer a breakthrough technology
that will drive new discoveries and patient analysis. Although the MRI field
is a multi-billion market, MRIs use materials such as gadolinium dies or
other processes that fail to produce the most efficient number of
resolutions to scans and signal to noise ratios. Our technology will solve
these issues,” Dr. Carpenter concluded.
QuantumSphere is the leading manufacturer of metallic nanopowders for
applications in the aerospace, defense, energy, biomedical and other markets
demanding advanced material applications. QuantumSphere enables
order-of-magnitude performance improvements for applications by using
nanotechnology in existing materials to make new, revolutionary products.
QuantumSphere is uniquely positioned to meet the market needs, as the firm’s
facility scales up to produce 2,500 pounds of the world’s purest
nanopowders, including nanonickel, a month.
About QuantumSphere, Inc.
QuantumSphere is the leading manufacturer of metallic nanopowders for
applications in the aerospace, defense, energy, biomedical and other markets
demanding advanced material applications. QuantumSphere’s exclusive
manufacturing process provides: consistent, narrow particle size
distribution; low level of agglomeration and impurities; custom-tailored
oxide shell thickness; and the highest purity metallic nanopowders on the
market that are easier to transport and handle. The company manufactures the
highest quality of metallic nanopowder in the industry without compromising
its commitment to the environment. No other company offers these performance
advantages.
QuantumSphere is the only supplier of the world’s highest quality nanonickel
(n-Ni). This will replace platinum as the main catalyst in hydrogen fuel
cells and provide a renewable source of power to supply the world’s energy
needs. The company is leveraging its leading market position in nanonickel
(n-Ni) to manufacture and ship product for applications in fuel cells,
magnetic medical products (e.g., contrast agent that is orders-of-magnitude
more sensitive than existing materials for MRI detection of disease and
organ function), and other applications including additives for plastics and
electromagnetic frequency shielding applications.
For more information, visit www.qsinano.com
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||